SKIN TISSUE HUMAN

Skin Tissue Human Adverse Events Reported to the FDA Over Time

How are Skin Tissue Human adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Skin Tissue Human, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Skin Tissue Human is flagged as the suspect drug causing the adverse event.

Most Common Skin Tissue Human Adverse Events Reported to the FDA

What are the most common Skin Tissue Human adverse events reported to the FDA?

Graft Complication	33 (4.24%)
Post Procedural Infection	32 (4.11%)
Graft Infection	30 (3.85%)
Infection	28 (3.59%)
Product Quality Issue	27 (3.47%)
Erythema	26 (3.34%)
Staphylococcal Infection	23 (2.95%)
Post Procedural Complication	18 (2.31%)
Skin Graft Infection	16 (2.05%)
Swelling	15 (1.93%)
Breast Cellulitis	13 (1.67%)
	Show More
Pseudomonas Infection	13 (1.67%)
Pyrexia	13 (1.67%)
Seroma	13 (1.67%)
Device Related Infection	12 (1.54%)
Secretion Discharge	12 (1.54%)
Impaired Healing	11 (1.41%)
Mycobacterium Fortuitum Infection	11 (1.41%)
Pain	11 (1.41%)
Breast Infection	10 (1.28%)
Device Failure	10 (1.28%)
Inflammation	10 (1.28%)
Procedural Site Reaction	9 (1.16%)
Postoperative Wound Complication	8 (1.03%)
Postoperative Wound Infection	8 (1.03%)
Serratia Infection	8 (1.03%)
Wound Drainage	8 (1.03%)
Wound Secretion	8 (1.03%)
Culture Positive	7 (.9%)
Skin Graft	7 (.9%)
Cellulitis	6 (.77%)
Surgical Procedure Repeated	6 (.77%)
Transmission Of An Infectious Agent...	6 (.77%)
Wound Dehiscence	6 (.77%)
Culture Wound Positive	5 (.64%)
Enterobacter Infection	5 (.64%)
Excessive Granulation Tissue	5 (.64%)
Implant Site Erythema	5 (.64%)
Incision Site Complication	5 (.64%)
Nausea	5 (.64%)
Autoimmune Disorder	4 (.51%)
Device Malfunction	4 (.51%)
Foreign Body Trauma	4 (.51%)
Hepatocellular Injury	4 (.51%)
Implant Site Infection	4 (.51%)
Implant Site Reaction	4 (.51%)
Incision Site Cellulitis	4 (.51%)
Incision Site Erythema	4 (.51%)
Necrosis	4 (.51%)
Post Procedural Bile Leak	4 (.51%)
Purulence	4 (.51%)
Purulent Discharge	4 (.51%)
Wound Infection	4 (.51%)
Wound Infection Staphylococcal	4 (.51%)
Abscess	3 (.39%)
Bacterial Infection	3 (.39%)
Beta Haemolytic Streptococcal Infec...	3 (.39%)
Breast Abscess	3 (.39%)
Complications Of Transplant Surgery	3 (.39%)
Culture Tissue Specimen Positive	3 (.39%)
Device Breakage	3 (.39%)
Disease Recurrence	3 (.39%)
Enterococcal Infection	3 (.39%)
Escherichia Infection	3 (.39%)
Failure Of Implant	3 (.39%)
Medical Device Complication	3 (.39%)
Medication Error	3 (.39%)
No Adverse Event	3 (.39%)
Open Wound	3 (.39%)
Post Procedural Oedema	3 (.39%)
Post Procedural Swelling	3 (.39%)
Sepsis	3 (.39%)
Staphylococcal Bacteraemia	3 (.39%)
Transplant Failure	3 (.39%)
Unevaluable Event	3 (.39%)
Vomiting	3 (.39%)
Wound Complication	3 (.39%)
Wound Infection Pseudomonas	3 (.39%)
Bacterial Test Positive	2 (.26%)
Breast Discharge	2 (.26%)
Breast Pain	2 (.26%)
Candidiasis	2 (.26%)
Device Leakage	2 (.26%)
Dyspareunia	2 (.26%)
Dyspnoea	2 (.26%)
Fusarium Infection	2 (.26%)
Gingival Graft	2 (.26%)
Hepatic Failure	2 (.26%)
Ill-defined Disorder	2 (.26%)
Immune System Disorder	2 (.26%)
Implant Expulsion	2 (.26%)
Implant Site Cellulitis	2 (.26%)
Implant Site Effusion	2 (.26%)
Implant Site Swelling	2 (.26%)
Incisional Drainage	2 (.26%)
Jaundice	2 (.26%)
Mycobacteria Tissue Specimen Test P...	2 (.26%)
Mycobacterial Infection	2 (.26%)
Nocardiosis	2 (.26%)
Nutritional Condition Abnormal	2 (.26%)
Off Label Use	2 (.26%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Skin Tissue Human, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Skin Tissue Human is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Skin Tissue Human

What are the most common Skin Tissue Human adverse events reported to the FDA?

Infections - Pathogen Unspecified	171 (21.95%)
Procedural And Device Related Injur...	158 (20.28%)
Bacterial Infectious	106 (13.61%)
Epidermal And Dermal Conditions	34 (4.36%)
Product Quality Issues	28 (3.59%)
Microbiology And Serology	20 (2.57%)
Administration Site Reactions	18 (2.31%)
Injuries	18 (2.31%)
Tissue	17 (2.18%)
Therapeutic Procedures And Supporti...	16 (2.05%)
Body Temperature Conditions	13 (1.67%)
	Show More
Mycobacterial Infectious	13 (1.67%)
Gastrointestinal Signs	10 (1.28%)
Hepatic And Hepatobiliary	8 (1.03%)
Ancillary Infectious Topics	7 (.9%)
Breast	7 (.9%)
Medication Errors	7 (.9%)
Skin And Subcutaneous Tissue Therap...	7 (.9%)
Skin And Subcutaneous Tissue	5 (.64%)
Autoimmune	4 (.51%)
Fungal Infectious	4 (.51%)
Immune	4 (.51%)
Cardiac Arrhythmias	3 (.39%)
Therapeutic And Nontherapeutic Effe...	3 (.39%)
Urinary Tract Signs	3 (.39%)
Genitourinary Tract	2 (.26%)
Head And Neck Therapeutic Procedure...	2 (.26%)
Hematology Investigations	2 (.26%)
Musculoskeletal And Connective Tiss...	2 (.26%)
Physical Examination Topics	2 (.26%)
Respiratory	2 (.26%)
Sexual Function And Fertility	2 (.26%)
Uterine, Pelvic And Broad Ligament	2 (.26%)
White Blood Cell	2 (.26%)
Abdominal Hernias And Other Abdomin...	1 (.13%)
Appetite And General Nutritional	1 (.13%)
Bladder And Bladder Neck Disorders	1 (.13%)
Bronchial Disorders	1 (.13%)
Electrolyte And Fluid Balance Condi...	1 (.13%)
Encephalopathies	1 (.13%)
Gastrointestinal	1 (.13%)
Injuries By Physical Agents	1 (.13%)
Investigations, Imaging And Histopa...	1 (.13%)
Lifestyle Issues	1 (.13%)
Mood Disorders	1 (.13%)
Oral Soft Tissue Conditions	1 (.13%)
Skin Appendage Conditions	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Skin Tissue Human, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Skin Tissue Human is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.